Physician profile
John Hansen
NPI 1679592372
$7,041.92
in general payments reported to CMS, 2019-2025
33 companies · $931 in 2025
The $931 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $983 · 2020: $126 · 2021: $445 · 2022: $2,364 · 2023: $1,214 · 2024: $978 · 2025: $931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,123.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,249.49 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $964.38 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit, Greenlight Xps |
| Procept Biorobotics Corporation | $421.97 | 2022-2024 | Aquabeam System, Aquabeam Robotic System |
| Astellas Pharma US INC | $360.44 | 2019-2023 | Veozah |
| Axonics, INC. | $305.73 | 2021-2023 | Axonics |
| Intuitive Surgical, INC. | $281.89 | 2019 | |
| Coloplast Corp | $280.38 | 2019-2023 | Titan, Speedicath |
| Pfizer INC. | $261.17 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $235.25 | 2024-2025 | |
| Urogen Pharma, INC. | $194.03 | 2022-2025 | Jelmyto |
| Janssen Biotech, INC. | $185.85 | 2025 | Carvykti, Rybrevant, Erleada |
| Pacira Pharmaceuticals Incorporated | $181.00 | 2022 | |
| Conmed Corporation | $148.40 | 2022 | |
| Progenics Pharmaceuticals, INC. | $142.46 | 2022-2023 | Pylarify |
| Olympus America INC. | $133.13 | 2023 | Itind System |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $116.02 | 2023 | Irrisept |
| Comsort, INC | $100.00 | 2019 | |
| Endo USA, INC. | $76.50 | 2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $59.67 | 2019-2025 | Adstiladrin |
| Urovant Sciences INC | $48.34 | 2022 | |
| Karl Storz Endoscopy-America | $45.56 | 2021 | |
| Sumitomo Pharma America, INC. | $41.20 | 2023-2024 | Gemtesa |
| Tolmar, INC. | $35.33 | 2025 | Eligard, Jatenzo |
| Endo Pharmaceuticals INC. | $30.79 | 2019-2020 | |
| Abbvie INC. | $22.29 | 2024 | |
| Myriad Genetic Laboratories, INC. | $20.88 | 2021 | |
| Abbott Laboratories | $20.03 | 2022 | |
| Merck Sharp & Dohme LLC | $17.77 | 2025 | Keytruda, Welireg |
| Sun Pharmaceutical Industries INC. | $14.14 | 2022 | |
| Accord Healthcare, INC. | $14.11 | 2023 | |
| Covidien LP | $12.23 | 2019 | |
| Biotissue Holdings INC. | $11.72 | 2021 | |
| Healthtronics Stone Solutions, LLC | $9.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.